Trials / Terminated
TerminatedNCT02739685
Bioresorbable Vascular Scaffolds Versus Stents in Patients With Chronic Total Occlusion
Everolimus-eluting Bioresorbable Vascular Scaffolds Versus Everolimus-eluting Stents in Patients With Chronic Total Occlusion
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 17 (actual)
- Sponsor
- University of Luebeck · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the current study is to demonstrate non-inferiority of everolimus-eluting bioresorbable vascular scaffold to everolimus-eluting stents in patients with chronic total occlusion regarding the antirestenotic efficacy at 8 to 10-month angiographic follow-up.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Everolimus-eluting bioresorbable vascular scaffold | Implantation of everolimus-eluting bioresorbable vascular scaffold in chronic total occlusion |
| DEVICE | Everolimus-eluting stent | Implantation of everolimus-eluting stent in chronic total occlusion |
Timeline
- Start date
- 2016-09-01
- Primary completion
- 2017-01-01
- Completion
- 2017-01-01
- First posted
- 2016-04-15
- Last updated
- 2019-09-26
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT02739685. Inclusion in this directory is not an endorsement.